Related Experiment Videos
Nicotine improves cognitive disturbance in senescence-accelerated mice
K Meguro1, S Yamaguchi, H Arai
1Department of Geriatric Medicine, Tohoku University, School of Medicine, Sendai, Japan.
Pharmacology, Biochemistry, and Behavior
|November 1, 1994
Summary
Nicotine administration improved learning in senescence-accelerated mice (SAM). These mice showed lower acetylcholine (ACh) levels, suggesting nicotine may boost cognitive function in aging.
Area of Science:
- Neuroscience
- Gerontology
- Pharmacology
Background:
- Senescence-accelerated mice (SAM) exhibit age-related cognitive decline.
- Acetylcholine (ACh) is a neurotransmitter crucial for learning and memory.
- Reduced ACh levels are associated with impaired cognitive function in aging models.
Purpose of the Study:
- To investigate acetylcholine (ACh) content in the brains of senescence-accelerated mice (SAM).
- To determine the effect of nicotine administration on learning ability in SAM-P/8 mice.
Main Methods:
- Measurement of ACh levels in brain tissues of SAM-P/8 (prone) and SAM-R/1 (resistant) mice.
- Assessment of learning ability using a passive avoidance task after nicotine administration (IP) in SAM-P/8 mice.
Main Results:
- SAM-P/8 mice displayed lower ACh content in the midbrain thalamus and hypothalamus compared to SAM-R/1 mice.
- Nicotine administration significantly improved the learning performance of SAM-P/8 mice in the passive avoidance task.
Conclusions:
- Lower brain ACh levels in SAM-P/8 mice correlate with accelerated senescence.
- Nicotine administration shows potential to enhance cognitive function in aging models with reduced ACh.
- Findings suggest nicotine as a possible therapeutic agent for age-related cognitive impairment.